The Immunisation Section of the Department of Health advises:
Quarantine your stock of Panvax H1N1 2009 Junior pre-filled syringes immediately.
To ensure the vaccine is no longer administered, quarantine your stock of Panvax H1N1 2009 Junior pre-filled syringes immediately. CSL is retrieving this stock and will contact you shortly.
Safety of the vaccine is not affected.
The Australian Technical Advisory Group on Immunisation (ATAGI) has advised the CMO that revaccination of children who have already received 2 doses of Panvax H1N1 2009 Junior is not necessary. The potency of the vaccine administered to date is considered adequate to induce an immune response.
If a child aged 6 months to <3 years of age is due to receive a second dose of H1N1 containing vaccine, this can be provided by using the age appropriate dose (0.25ml) obtained from a Panvax multi-dose vial.
Alternatively, the 2010 seasonal influenza vaccines (Vaxigrip and Influvac) are also suitable for use. Panvax multi-dose vials and Vaxigrip and Influvac influenza vaccines are not affected.
ATAGI's full advice will be available shortly on www.healthemergency.gov.au and www.immunise.health.gov.au
